Corrigendum to 'A state-wide Population-based Evaluation of Cervical Cancers Arising during Opportunistic Screening in the United States' [Gynecologic Oncology 159 (2020) 344-353]

Authors

Rebecca Landy, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USAFollow
Christopher Mathews, School of Cancer & Pharmaceutical Sciences, King's College London, London SE1 9RT, United Kingdom
Michael Robertson, University of New Mexico Comprehensive Cancer Center, The Center for HPV Prevention, University of New Mexico Health Sciences Center, Albuquerque, NM, USA
Charles L. Wiggins, University of New Mexico Comprehensive Cancer Center, Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA
Yolanda J. McDonald, Department of Human and Organizational Development, Vanderbilt University, Nashville, TN, USA
Daniel W. Goldberg, Department of Geography, Texas A&M University, College Station, TX, USA
Isabel C. Scarinci, Division of Preventive Medicine, University of Alabama at Birmingham, AL, USA
Jack Cuzick, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom
Peter D. Sasieni, School of Cancer & Pharmaceutical Sciences, King's College London, London SE1 9RT, United Kingdom
Cosette M. Wheeler, Departments of Pathology and Obstetrics & Gynecology, University of New Mexico Health Sciences Center, Albuquerque, NM, USA

Document Type

Article

Publication Date

12-16-2021

Recommended Citation

Landy R, Mathews C, Robertson M, Wiggins CL, McDonald YJ, Goldberg DW, Scarinci IC, Cuzick J, Sasieni PD, Wheeler CM; New Mexico HPV Pap Registry (NMHPVPR) Steering Committee Members. Corrigendum to 'A state-wide population-based evaluation of cervical cancers arising during opportunistic screening in the United States' [Gynecologic Oncology 159 (2020) 344-353]. Gynecol Oncol. 2021 Dec;163(3):614. doi: 10.1016/j.ygyno.2021.09.020. Epub 2021 Oct 1. Erratum for: Gynecol Oncol. 2020 Nov;159(2):344-353. PMID: 34602285.